Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients (Q42644052)
Jump to navigation
Jump to search
scientific article published on 23 December 2004
Language | Label | Description | Also known as |
---|---|---|---|
English | Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients |
scientific article published on 23 December 2004 |
Statements
1 reference
Medial temporal lobe atrophy and APOE genotype do not predict cognitive improvement upon treatment with rivastigmine in Alzheimer's disease patients (English)
1 reference
Philip Scheltens
1 reference
Frans R J Verhey
1 reference
Pieter Jelle Visser
1 reference
Esther Pelgrim
1 reference
Dutch ENA-NL-01 Study Group
1 reference
23 December 2004
1 reference
1 reference
19
1 reference
2-3
1 reference
126-133
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference